[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100548782":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":32,"responsibleParty":50,"collaborators":11,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":11,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":11,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":11,"overallStatus":35,"whyStopped":11,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"The University of Texas Health Science Center, Houston","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"KARL STORZ fetoscope arm","EXPERIMENTAL",null,[13],"Device: KARL STORZ fetoscope arm",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":11},"DEVICE","The type of fetoscope used in utero(either straight or curved or both ) will depend on the location of the placenta. The fetoscope will be used to cauterize abnormal blood vessels that cause twin-to-twin transfusion syndrome (TTTS)",[9],[20],{"name":21,"affiliation":5,"role":22},"Jimmy Espinoza, MD, MSc,FACOG","PRINCIPAL_INVESTIGATOR",[24,28],{"name":21,"role":25,"phone":26,"phoneExt":11,"email":27},"CONTACT","(713) 500-5859","Jimmy.Espinoza@uth.tmc.edu",{"name":29,"role":25,"phone":30,"phoneExt":11,"email":31},"Elisa Garcia","713-500-6347","Elisa.I.Garcia@uth.tmc.edu",[33],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"The University of Texas health Science Center at Houston","RECRUITING","Houston","Texas","77030","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-95.36327,29.76328,{"lat":45,"lon":44},[48,49],{"name":21,"role":25,"phone":26,"phoneExt":11,"email":27},{"name":29,"role":25,"phone":30,"phoneExt":11,"email":31},{"type":22,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"Jimmy Espinoza","Professor","100548782","the-use-of-karl-storz-curved-fetoscope-11508aak-and-its-straight-version-11506akk-for-in-utero-surgery-100548782",false,"NCT06425471","The Use of Karl Storz Curved Fetoscope (11508aak) and Its Straight Version (11506akk) for In-utero Surgery","A Prospective Study on the Efficacy of the Karl Storz Curved Fetoscope (11508aak) and Its Straight Version (11506akk) for In-utero Surgery","Inclusion Criteria:\n\n* Pregnant woman\n* The patient fulfills the criteria for in-utero surgery based on the standard of care, which is specific for each condition\n* Patient of the baby provides signed informed consent that details the maternal and fetal risks involved with the procedure\n\nExclusion Criteria:\n\n* Contraindication to abdominal surgery, fetoscopic surgery, or general anesthesia\n* Allergy or previous adverse reaction to a study medication specified in this protocol\n* Preterm labor, preeclampsia, or a uterine anomaly (e.g., large fibroid tumor) that is unavoidable during surgery in the index pregnancy\n* Fetal aneuploidy, genomic variants of known significance if an amniocentesis has been performed, other major fetal anomalies or disorders that may impact the fetal\u002Fneonatal survival, or a known syndromic mutation\n* Suspicion of a major recognized syndrome by ultrasound or MRI\n* Maternal BMI \\>40 kg\u002Fm2\n* High risk for fetal hemophilia","FEMALE","18 Years","45 Years",{"count":64,"type":65},50,"ESTIMATED","INTERVENTIONAL",[68],"NA","The purpose of this study is to prospectively evaluate the efficacy of KARL STORZ curved fetoscope (11508AAK) and its straight version (11506AAK) for in-utero surgery",[71],"In Utero Procedure Affecting Fetus or Newborn","2025-08-11",{"date":74,"type":75},"2025-08-14","ACTUAL",{"date":77,"type":75},"2024-04-04",{"date":79,"type":65},"2028-12-31",{"name":5,"class":6},1]